<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85415</article-id><article-id pub-id-type="doi">10.7554/eLife.85415</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-301857"><name><surname>Liang</surname><given-names>Jiurong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-301858"><name><surname>Huang</surname><given-names>Guanling</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301859"><name><surname>Liu</surname><given-names>Xue</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301860"><name><surname>Liu</surname><given-names>Ningshan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301861"><name><surname>Taghavifar</surname><given-names>Forough</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301862"><name><surname>Dai</surname><given-names>Kristy</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301863"><name><surname>Yao</surname><given-names>Changfu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301864"><name><surname>Deng</surname><given-names>Nan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301865"><name><surname>Wang</surname><given-names>Yizhou</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301866"><name><surname>Chen</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301867"><name><surname>Hogaboam</surname><given-names>Cory</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271015"><name><surname>Stripp</surname><given-names>Barry R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-301868"><name><surname>Parks</surname><given-names>William C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-109584"><name><surname>Noble</surname><given-names>Paul W</given-names></name><email>paul.noble@cshs.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-231129"><name><surname>Jiang</surname><given-names>Dianhua</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4508-3829</contrib-id><email>dianhua.jiang@cshs.org</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Department of Medicine and Women’s Guild Lung Institute, Cedars-Sinai Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Genomics Core, Cedars-Sinai Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02pammg90</institution-id><institution>Department of Biomedical Sciences, Cedars-Sinai Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kraft</surname><given-names>Monica</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>06</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e85415</elocation-id><history><date date-type="received" iso-8601-date="2022-12-07"><day>07</day><month>12</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-06-13"><day>13</day><month>06</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-07-30"><day>30</day><month>07</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.07.30.227892"/></event></pub-history><permissions><copyright-statement>© 2023, Liang, Huang et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Liang, Huang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85415-v2.pdf"/><abstract><p>Aging is a critical risk factor in idiopathic pulmonary fibrosis (IPF). Dysfunction and loss of type 2 alveolar epithelial cells (AEC2s) with failed regeneration is a seminal causal event in the pathogenesis of IPF, although the precise mechanisms for their regenerative failure and demise remain unclear. To systematically examine the genomic program changes of AEC2s in aging and after lung injury, we performed unbiased single-cell RNA-seq analyses of lung epithelial cells from uninjured or bleomycin-injured young and old mice, as well as from lungs of IPF patients and healthy donors. We identified three AEC2 subsets based on their gene signatures. Subset AEC2-1 mainly exist in uninjured lungs, while subsets AEC2-2 and AEC2-3 emerged in injured lungs and increased with aging. Functionally, AEC2 subsets are correlated with progenitor cell renewal. Aging enhanced the expression of the genes related to inflammation, stress responses, senescence, and apoptosis. Interestingly, lung injury increased aging-related gene expression in AEC2s even in young mice. The synergistic effects of aging and injury contributed to impaired AEC2 recovery in aged mouse lungs after injury. In addition, we also identified three subsets of AEC2s from human lungs that formed three similar subsets to mouse AEC2s. IPF AEC2s showed a similar genomic signature to AEC2 subsets from bleomycin-injured old mouse lungs. Taken together, we identified synergistic effects of aging and AEC2 injury in transcriptomic and functional analyses that promoted fibrosis. This study provides new insights into the interactions between aging and lung injury with interesting overlap with diseased IPF AEC2 cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>lung injury</kwd><kwd>aging</kwd><kwd>alveolar progenoitor</kwd><kwd>idiopathic pulmonary fibrosis</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R0-1AG078655</award-id><principal-award-recipient><name><surname>Liang</surname><given-names>Jiurong</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R35-HL150829</award-id><principal-award-recipient><name><surname>Noble</surname><given-names>Paul W</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>R01-HL060539</award-id><principal-award-recipient><name><surname>Noble</surname><given-names>Paul W</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000050</institution-id><institution>National Heart, Lung, and Blood Institute</institution></institution-wrap></funding-source><award-id>P01-HL108793</award-id><principal-award-recipient><name><surname>Jiang</surname><given-names>Dianhua</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The synergy between aging and injury impairs alveolar progenitor functions leading to progressive lung fibrosis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Type 2 alveolar epithelial cells (AEC2s) function as progenitor cells that maintain epithelial homeostasis and repair damaged epithelium after lung injury (<xref ref-type="bibr" rid="bib3">Barkauskas et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Desai et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Hogan et al., 2014</xref>; <xref ref-type="bibr" rid="bib23">Jiang et al., 2020a</xref>). Distal lung epithelial progenitor cell function declines (<xref ref-type="bibr" rid="bib44">Watson et al., 2020</xref>) and gene expression profiles change in AEC2s with aging (<xref ref-type="bibr" rid="bib32">McQuattie-Pimentel et al., 2021</xref>).</p><p>Aging is an important risk factor in idiopathic pulmonary fibrosis (IPF) (<xref ref-type="bibr" rid="bib19">Hecker, 2018</xref>; <xref ref-type="bibr" rid="bib18">Hecker et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Thannickal, 2013</xref>). The incidence, prevalence, and mortality of IPF all increase with age (<xref ref-type="bibr" rid="bib35">Raghu et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Rojas et al., 2015</xref>). Growing evidence suggests that IPF is a result of alveolar epithelial dysfunction and inadequate regenerative capacity that leads to basal-like cell expansion and excessive fibroblast activation with matrix deposition and destruction of the normal lung architecture (<xref ref-type="bibr" rid="bib4">Borok et al., 2020</xref>; <xref ref-type="bibr" rid="bib13">Cho and Stout-Delgado, 2020</xref>; <xref ref-type="bibr" rid="bib33">Noble et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Schneider et al., 2021</xref>). Both the numbers and progenitor cell renewal capacity of AEC2s in IPF lungs are signinficantly reduced (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Xu et al., 2016</xref>). Phenotypes of cellular aging in AEC2s including mitochondrial dysfunction (<xref ref-type="bibr" rid="bib5">Bueno et al., 2018</xref>), senescence (<xref ref-type="bibr" rid="bib22">Jiang et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Yao et al., 2021</xref>), endoplasmic reticulum (ER) stress (<xref ref-type="bibr" rid="bib6">Burman et al., 2018</xref>), and premature lung aging (<xref ref-type="bibr" rid="bib12">Chilosi et al., 2013</xref>) have been described in IPF. However, the interplay between aging, injury, and AEC2 progenitor dysfunction and renewal in IPF are not fully understood.</p><p>Heterogeneity in distal lung epithelial cells has been increasingly recognized in recent studies. Subclusters of alveolar epithelial cells are distributed differently between human fibrotic and healthy donor lungs (<xref ref-type="bibr" rid="bib1">Adams et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Habermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Reyfman et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Yao et al., 2021</xref>). AEC2 subsets were reported in mouse lungs after lipopolysaccharides (LPS) injury (<xref ref-type="bibr" rid="bib24">Jiang et al., 2020b</xref>; <xref ref-type="bibr" rid="bib37">Riemondy et al., 2019</xref>), following pneumonectomy (<xref ref-type="bibr" rid="bib45">Wu et al., 2020</xref>), as well as with TiO<sub>2</sub> exposure (<xref ref-type="bibr" rid="bib25">Joshi et al., 2020</xref>). Subclusters of Krt8-positive AEC2s (<xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>) and CLDN4-expressing AEC2s were reported in IPF (<xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>) and bleomycin-injured mouse lungs (<xref ref-type="bibr" rid="bib14">Choi et al., 2020</xref>). KRT5<sup>−</sup>/KRT17<sup>+</sup> cells accumulated in human lungs with pulmonary fibrosis (<xref ref-type="bibr" rid="bib17">Habermann et al., 2020</xref>). However, there is a paucity of comprehensive studies examining AEC2 subsets and their effector functions in the context of the combination of aging, lung injury, and lung fibrosis.</p><p>In the current study, we took an unbiased approach – single-cell RNA-sequencing (scRNA-seq) of primary flow cytometry-enriched lung epithelial cells – to systematically investigate the genetic signatures and programs of AEC2s in young and old mouse lungs under homeostasis and after experimental fibrotic lung injury, and comparatively examined these genetic programs in AEC2s from IPF and heathy donor lungs. Interestingly, we identified three subsets of AEC2s based on gene expression profiling. The genomic programming changes of AEC2 subsets were correlated with lung injury and influenced by aging. Most importantly, our data revealed a previously unrecognized interaction between aging and AEC2 injury which contributed to impaired AEC2 progenitor function. Furthermore, AEC2s from IPF lungs have similar gene signatures as AEC2s from bleomycin-injured old but not young mouse lungs.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Defining epithelial cell transcriptome profiles in young and old mouse lungs</title><p>To better focus our investigation on the genetic signatures and programs of lung alveolar epithelial cells during aging and following lung injury, we performed scRNA-seq on flow sorted epithelial cells (EpCAM<sup>+</sup>CD31<sup>−</sup>CD34<sup>−</sup>CD45<sup>−</sup>) from lungs of uninjured (day 0), 4, 14, and 28 days post bleomycin injury of young and old mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). A total of 96,213 cells were analyzed, and the cells from 26 individual mice overlapped very well (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). The major lung epithelial cell types, AEC2, AEC1, basal cells, club cells, ciliated cells, pulmonary neuroendocrine cells, and proliferative cells were readily identified with canonical cell markers (<xref ref-type="fig" rid="fig1">Figure 1C–E</xref>). The AEC2 cluster was the largest among the lung epithelial cell populations (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The general aging marker genes, including <italic>B2M</italic>, <italic>H2-K1</italic>, <italic>H2-D1</italic>, <italic>H2-Q7</italic>, and <italic>CHIA1</italic> were all upregulated in AEC2s from uninjured old mice (<xref ref-type="fig" rid="fig1">Figure 1F, G</xref>), consistent with previous reports (<xref ref-type="bibr" rid="bib2">Angelidis et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">López-Otín et al., 2013</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Transcriptome profiles of lung epithelial cells in young and old mice.</title><p>(<bold>A</bold>) Schematic of scRNA-seq analysis of flow sorted EpCAM<sup>+</sup>CD31<sup>−</sup>CD34<sup>−</sup>CD45<sup>−</sup> cells from lungs of uninjured (day 0) (<italic>n</italic> = 3), day 4 (<italic>n</italic> = 4), day 14 (<italic>n</italic> = 3), and day 28 post injury (<italic>n</italic> = 3) young and old mice. (<bold>B</bold>) Uniform Manifold Approximation and Projection (UMAP) visualization of 96,213 cells from all 26 samples. (<bold>C</bold>) UMAP visualization of epithelial cell clusters. (<bold>D</bold>) Heatmap of epithelial cell clusters. (<bold>E</bold>) Dot plots of conventional marker genes of epithelial cell clusters. (<bold>F, G</bold>) Gene expression in type 2 alveolar epithelial cells (AEC2s) from old vs young uninjured mice.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>AEC2 subsets with aging and lung injury</title><p>AEC2 heterogenity following lung injury in mouse models has been extensively reported (<xref ref-type="bibr" rid="bib25">Joshi et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Kobayashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Riemondy et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Wu et al., 2020</xref>). However, there is an incomplete understanding of AEC2 subsets under the influence of both aging and lung injury. We therefore analyzed the gene expression of a total of 57,717 AEC2s from both homeostatic and bleomycin-injured young and old mouse lungs, and identified three AEC2 subsets, AEC2-1, AEC2-2, and AEC2-3 according to their gene expression signatures (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref>). AEC2-2 showed the lowest correlation silhouette value suggesting an intermediate status between AEC2-1 and AEC2-3 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Pseudotime analysis identified the AEC2-1 subset with the lowest entropy and AEC2-3 with the highest entropy, suggesting a transition from AEC2-1 to AEC2-2 and further to AEC2-3 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Correlation spanning tree analysis supported these sequential dynamics (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Furthermore, RNA trajectory analysis using a cell lineage and pseudotime inference tool, Slingshot (<xref ref-type="bibr" rid="bib41">Street et al., 2018</xref>), confirmed that subset AEC2-3 cells were from subset AEC2-1 via subset AEC2-2, and AEC1 cells were from subset AEC2-3 cells in both young and old mice lungs, although further heterogeneity existed in AEC2-3 clusters (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Definition of type 2 alveolar epithelial cell (AEC2) subsets.</title><p>(<bold>A</bold>) UMAP of 57,717 AEC2s showing in three subsets of AEC2s (red, AEC2-1; green, AEC2-2; and blue, AEC2-3). (<bold>B</bold>) Heatmap representing characteristics of three subsets of AEC2s. Each column represents the average expression value for one cell, grouped by cell cluster. Gene expression values are normalized in rows. (<bold>C</bold>) Correlation silhouette of AEC2 subsets. (<bold>D</bold>) Pseudotime analysis and correlation spanning tree of AEC2 subsets. (<bold>E</bold>) Slingshot trajectory inference analysis showed the lineage reconstructions of the AEC2 subsets and AEC1 clusters from young and old lungs. (<bold>F–M</bold>) Violin plots of gene expression in AEC2 subsets (red, AEC2-1; green, AEC2-2; and blue, AEC2-3). Expression of subset AEC2-1 marker genes (<bold>F</bold>), expression of subset AEC2-2 marker genes (<bold>G</bold>), expression of claudin family genes (<bold>H</bold>), expression of heat shock protein family genes (<bold>I</bold>), expression of S100 protein family genes (<bold>J</bold>), expression of <italic>Cdkn1</italic>a and annexin family genes (<bold>K</bold>), expression of <italic>Atf3</italic> and <italic>Atf4</italic> (<bold>L</bold>), and expression of the keratin family genes (<bold>M</bold>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig2-v2.tif"/></fig><p>Subset AEC2-1 cells express typical signature genes of AEC2s including <italic>Sftpc</italic>, <italic>Sftpb</italic>, <italic>Sftpa1</italic>, <italic>Napsa</italic>, <italic>Abca3</italic>, and <italic>Etv5</italic>. All these AEC2 marker genes were significantly downregulated in subsets AEC2-3 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p><p>Increased interferon (IFN) signaling was observed in AEC2-2 cells with increased expression of IFN-induced genes, <italic>Ifi27</italic> and <italic>Ifi2712a</italic> (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Other genes upregulated in subset AEC2-2 cells included <italic>Lcn2</italic>, <italic>Cd74</italic>, <italic>Cldn18</italic>, <italic>Bcam</italic>, and <italic>Gas6</italic> (<xref ref-type="fig" rid="fig2">Figure 2G</xref>).</p><p>Several gene families were upregulated in subset AEC2-3. <italic>Cldn4</italic> was expressed only in AEC2-3 cells, while <italic>Cldn3</italic> and <italic>Cldn7</italic> were expressed in all three subsets of AEC2s with highest expression in AEC2-3 (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Gene families include the heat shock protein family (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), S100 proteins (<xref ref-type="fig" rid="fig2">Figure 2J</xref>), senescence and apoptosis family (<xref ref-type="fig" rid="fig2">Figure 2K</xref>), endoplasmic reticulum (ER) stress-related genes (<xref ref-type="fig" rid="fig2">Figure 2L</xref>), and keratin genes (<xref ref-type="fig" rid="fig2">Figure 2M</xref>) were all upregulated in subset AEC2-2 and their expression was further elevated in subset AEC2-3.</p><p>Pathway analyses idenfitified that both subsets AEC2-2 and AEC2-3 showed upregulated oxidative phosphorylation and NRF2-mediated oxidative stress response genes, compared to subset AEC2-1 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b</xref>). The EIF2 signaling, eIF4 and p70S6K signaling, and mTOR signaling pathways were upregulated in subsets AEC2-2 and AEC2-3 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b</xref>). In addition, both subset 2 and 3 AEC2s showed increased unfolded protein response, p53 signaling, and apoptosis signaling pathways relative to subset 1 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a, b</xref>). IFN signaling was upregulated in subset AEC2-2 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). These data suggest that the cells in AEC2-2 and AEC2-3 were demonstrating stress responses.</p><p>The gene signature and signaling pathways of these three AEC2 subsets indicated that AEC2s in subset AEC2-1 were intact, homeostatic AEC2s, while subset AEC2-2 and subset AEC2-3 were injured AEC2s.</p></sec><sec id="s2-3"><title>Dynamic of AEC2 subsets in aging and lung injury</title><p>Next, we investigated how aging and lung injury affected the subsets of AEC2s. Four days post bleomycin injury is the time point with maximum AEC2 injury, and by days 14 and 28 post injury there is substantial AEC2 recovery (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>). Over 80% of total AEC2s in uninjured young mouse lungs were subset AEC2-1 cells and the percentage of AEC2-1 cells was slightly lower in the uninjured old mouse lungs (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). At day 4 post bleomycin injury, AEC2s shifted from subset AEC2-1 to AEC2-2 and AEC2-3 in both young and old mouse lungs. It is interesting that at day 14 post bleomycin injury, during recovery, the intact AEC2s in AEC2-1 subset were partially recovered in young mouse lungs (from 29.05% at day 4 to 60.46% at day 14 post bleomycin injury), but the old mouse lungs were continuously losing cells in the AEC2-1 subset (from 41.44% at day 4 to 18.83% at day 14 post bleomycin injury). The majority of AEC2s in old mouse lungs at day 14 post bleomycin injury were subset AEC2-3 cells (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). There was some degree of recovery of subset AEC2-1 in old mouse lungs at day 28 compared to day 14 post bleomycin injury (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>). However, the old mouse lungs continued to have much lower percentages of AEC2-1 (old 34% vs young 54%) and higher percentages of AEC2-3 (old 46% vs young 12%) at day 28 relative to that of the lungs from young mice (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). These data suggest that aging affects AEC2 subset evolution in the lung with a reduced subset of intact AEC2s and increased proportions of damaged AEC2s in old mouse lungs, especially after injury.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Type 2 alveolar epithelial cells (AEC2s) subsets were influenced by both aging and lung injury.</title><p>(<bold>A</bold>) UMAP showing the distributions of the three subsets of AEC2s grouped by age and injury date (red, AEC2-1; green, AEC2-2; and blue, AEC2-3. Y = young; O = old). (<bold>B</bold>) Percentage of AEC2 subsets grouped by age and injury date (red, AEC2-1; green, AEC2-2; and blue, AEC2-3). (<bold>C</bold>) Colony-forming efficiency (CFE) of AEC2s from uninjured and day 4 bleomycin-injured young mice (<italic>n</italic> = 6–8, ****p &lt; 0.0001). (<bold>D</bold>) CFE of CLDN4+ and CLDN4− AEC2s isolated at day 14 after bleomycin treatment (<italic>n</italic> = 7–8, ****p &lt; 0.0001). <italic>Sftpc</italic> (<bold>E</bold>) and <italic>Pdpn</italic> (<bold>F</bold>) expression of CLDN4+ and CLDN4− AEC2s derived from 3D cultured organoids by reverse transcription-polymerase chain reaction (RT-PCR) (<italic>n</italic> = 4, ****p &lt; 0.0001, *p &lt; 0.05). (C-F) Statistical anayses were by unpaired two-tailed Student’s <italic>t</italic>-test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig3-v2.tif"/></fig><p>We then interrogated the progenitor functions of the AEC2 subsets we identified. We flow sorted primary AEC2s (<xref ref-type="bibr" rid="bib29">Liang et al., 2022</xref>; <xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>) from uninjured and day 4 bleomycin-injured young mice and applied the cells to 3D orgnoid cultures. The renewal capacity of AEC2s was measured by colony-forming efficiency (CFE). AEC2s from bleomycin-injured lungs had decreased regenerative capacity compared to AEC2s from uninjured lungs as demonstrated by decreased CFEs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Since Claudin-4 (CLDN4) was only expressed in subset AEC2-3, we used CLDN4 as a cell surface marker to flow sort subset AEC2-3 cells (EpCAM<sup>+</sup>CD31<sup>−</sup>CD34<sup>−</sup>CD45<sup>−</sup>CD24<sup>−</sup>Sca-1<sup>−</sup>CLDN4<sup>+</sup>) from mouse lungs at day 14 after bleomycin injury and compared the CFEs to AEC2s in subset AEC2-1 and AEC2-2 (EpCAM<sup>+</sup>CD31<sup>−</sup>CD34<sup>−</sup>CD45<sup>−</sup>CD24<sup>−</sup>Sca-1<sup>−</sup>CLDN4<sup>−</sup>). Our results showed that CLDN4-positive AEC2s had significantly reduced regenerative capacity relative to that of CLDN4-negative AEC2s (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). We further showed that AEC2s derived from CLDN4-positive organoids had decreased <italic>Sftpc</italic> and <italic>Pdpn</italic> expression compared to that of AEC2s form CLDN4-negative organoids by RT-PCR (<xref ref-type="fig" rid="fig3">Figure 3E, F</xref>), suggesting decreased AEC2 integrity and differentiation capacity of CLND4-positive AEC2-3 cells.</p></sec><sec id="s2-4"><title>Aging enhanced injury-related gene expression in AEC2s</title><p>The altered AEC2 subsets in bleomycin-injured aged mouse lungs suggested aging has an important impact on gene expression and function of AEC2s during lung injury. To gain further insights into the impact of aging on AEC2 injury and repair, we compared gene expression in AEC2s from young and old mice at multiple time points after bleomycin treatment. As expected, bleomycin injury increased the expression of inflammation and oxidative stress-related genes (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), S100 family genes (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), heat shock protein family genes (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), senescence (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) and apoptosis (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), and ER stress-related genes (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Interestingly, aged AEC2s showed lower response compared to that of young AEC2s at day 4 after bleomycin treatment, while the expression levels of all these genes were elevated in aged AEC2s compared to that of young AEC2s at the later time points (<xref ref-type="fig" rid="fig4">Figure 4A–F</xref>), suggesting exaggerated AEC2 injury and delayed recovery with aging.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Aging enhanced type 2 alveolar epithelial cell (AEC2) injury with bleomycin time course.</title><p>Violin plots of gene expression in AEC2 from young and old mice at baseline day (D) 0 and days 4, 14, and 28 after bleomycin treatment. (<bold>A</bold>) Inflammatory and oxidative stress-related genes in AEC2s grouped by age and injury date; (<bold>B</bold>) S100a family genes; (<bold>C</bold>) heat shock protein family genes; (<bold>D</bold>) Senescence gene; (<bold>E</bold>) apoptosis-related genes; (<bold>F</bold>) ER stress-related genes; (<bold>G</bold>) keratin family genes; and (<bold>H</bold>) claudin family genes. Red, young; blue, old.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig4-v2.tif"/></fig><p>Reports showed that several AEC2 subsets including Krt8 expressing AEC2s (<xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>) and Cldn4-expressing AEC2s (<xref ref-type="bibr" rid="bib26">Kobayashi et al., 2020</xref>) were transitional AEC2s which accumulated in bleomycin-injured mouse lungs. We therefore analyzed the effect of aging on the expression of these genes in AEC2s following bleomycin injury over time. Indeed, the expression of multiple genes in the keratin family including <italic>Krt7</italic>, <italic>Krt8</italic>, <italic>Krt18</italic>, and <italic>Krt19</italic> were all upregulated and further increased in aged AEC2s after bleomycin injury (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). The expression level of Krt17 was very low in mouse AEC2s but with a trend toward increase with injury and aging (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). It was reported that Krt17-expressing AEC2s accumulated in IPF lungs (<xref ref-type="bibr" rid="bib17">Habermann et al., 2020</xref>). The expression of keratin family genes peaked at day 4 and declined toward baseline levels at days 14 and 28 in AEC2s from young mice. However, the expression of keratin genes remained high at days 14 and 28 in AEC2s from old mice (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). Multiple claudin family genes including <italic>Cldn3</italic>, <italic>Cldn7</italic>, and <italic>Cldn8</italic> were upregulated after bleomycin injury and further elevated with aging (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). <italic>Cldn4</italic> expression was very low in uninjured AEC2s and its expression increased with bleomycin injury and aging (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). This result is consistent with what we showed in <xref ref-type="fig" rid="fig2">Figure 2H</xref> that Cldn4 was mainly expressed in subset AEC2-3 cells. The persistently elevated expression of both Krt8 and Cldn4 in AEC2s from aged mice at later time points of bleomycin injury suggested further impaired AEC2 differentiation to AT1 cells with aging after lung injury.</p></sec><sec id="s2-5"><title>Injury elevated aging-related gene expression in AEC2s</title><p>Lung injury promotes AEC2 senescence which is also a signature of aging (<xref ref-type="bibr" rid="bib27">Lee et al., 2012</xref>). To gain insight into how injury can influence aging-related genetic changes in AEC2s, we analyzed aging hallmark genes expressed in AEC2s from young and old mice after bleomycin injury. Interestingly, the expression of multiple aging-related genes including class II histone protein genes (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and other aging hallmark genes including <italic>B2m</italic>, <italic>Ybx1</italic>, <italic>Clu</italic>, <italic>Tspo</italic>, and <italic>Npm1</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>) were elevated in bleomycin-injured AEC2s from both young and old mice. The expression levels of aging hallmark genes were equally high in injured young and aged AEC2s at day 4 after bleomycin treatment (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>). These results suggested that not only aging affects AEC2 function after injury, but injury also skews AEC2s toward aging-like genetic changes.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Injury-induced aging-related gene expression in type 2 alveolar epithelial cells (AEC2s).</title><p>Violin plots of aging-related gene expression in AEC2 from young and old mice at baseline day (D) 0 and days 4, 14, and 28 after bleomycin treatment. (<bold>A</bold>) Histocompatibility 2 genes. (<bold>B</bold>) Aging hallmark genes. Red, young; blue, old.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig5-v2.tif"/></fig></sec><sec id="s2-6"><title>Impaired AEC2 recovery in bleomycin-injured aged mouse lungs</title><p>Our data suggest that aging enhances inflammatory and stress response, senescence, ER stress, and apoptosis-related gene expression in AEC2s after lung injury, meanwhile injury skewed the gene expression in AEC2s toward aging-like changes. We anticipated that this interaction between aging and injury of AEC2s would impaire AEC2 recovery in aged mouse lungs after bleomycin injury. We first examined expression of AEC2 marker genes in AEC2s from young and old mice following bleomycin treatement over time. Multiple surfactant genes including <italic>Sftpc</italic>, <italic>Sftpb</italic>, <italic>Sftpa1</italic>, and several other AEC2 marker genes including <italic>Abca3</italic>, <italic>Slc34a2</italic>, <italic>Lyz2</italic>, and <italic>Etv5</italic> were all downregulated in both young and old AEC2s at day 4, the time point with maximum AEC2 injury after bleomycin treatment. The expression of AEC2 marker genes in AEC2s from young mice were recovered close to baseline levels at days 14 and 28 but their expression in AEC2s from old mice remained reduced even at day 28 (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Old mouse lungs contained fewer AEC2s at baseline without injury (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The numbers of AEC2s in old mouse lungs at day 28 after bleomycin-injured were further reduced relative to that of young mice due to impaire AEC2 recovery with aging (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The decreased AEC2 recovery in bleomycin-injured old mice was aligned with senescence and impaired progenitor renewal of AEC2s with aging (<xref ref-type="bibr" rid="bib11">Childs et al., 2015</xref>; <xref ref-type="bibr" rid="bib29">Liang et al., 2022</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Decreased renewal capacity of injured aged type 2 alveolar epithelial cells (AEC2s).</title><p>(<bold>A</bold>) Violin plots of gene expression in AEC2 from young and old mice at baseline day (D) 0 and days 4, 14, and 28 after bleomycin treatment. Red, young; blue, old. (<bold>B</bold>) Number of AEC2s recovered from uninjured young and old mice (<italic>n</italic> = 5–6, ***p &lt; 0.001, by unpaired two-tailed Student’s <italic>t</italic>-test). (<bold>C</bold>) Number of AEC2s recovered from bleomycin day 28 young and old mouse lungs (<italic>n</italic> = 3–5, ****p &lt; 0.0001, by unpaired two-tailed Student’s <italic>t</italic>-test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig6-v2.tif"/></fig></sec><sec id="s2-7"><title>IPF AEC2s showed similar gene signature patterns as injured aged murine AEC2s</title><p>It was reported that an AEC2 subset representing transitional AEC2s exist in both bleomycin-injured mouse lungs and human IPF lungs (<xref ref-type="bibr" rid="bib21">Huang and Petretto, 2021</xref>), suggesting a similarity in AEC2 subsets between mouse fibrosis and IPF. Next, we determined if the three AEC2 subsets we identified in the mouse model was relevant to human disease. We analyzed scRNA-seq data of flow cytometry-enriched lung epithelial (EpCAM<sup>+</sup>CD31<sup>−</sup>CD45<sup>−</sup>) cells from lung tissues of six IPF patients (11,381 cells) and six healthy donors (14,687 cells) (<xref ref-type="bibr" rid="bib29">Liang et al., 2022</xref>). IPF AEC2s had a singificant decrease in expression of classical AEC2 genes including <italic>SFTPC</italic>, <italic>SLC34A2</italic>, <italic>ABCA3</italic>, and <italic>ETV5</italic>, when compared with AEC2s from healthy donors (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). IPF AEC2s showed strong IFN signaling with a higher IFN activation score and elevated gene expression of <italic>IFI27</italic> (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Genes including <italic>LCN2</italic>, <italic>CD74</italic>, <italic>BCAM</italic>, and <italic>GAS6</italic> were significantly upregulated in IPF AEC2s (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) which are the same group of genes that were upregulated in mouse subset AEC2-2.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Idiopathic pulmonary fibrosis (IPF) type 2 alveolar epithelial cells (AEC2s) share the gene signatures of mouse AEC2 subsets AEC2-2 and AEC2-3.</title><p>(<bold>A</bold>) Violin plots of expression of mouse AEC2-1 signature genes in healthy and IPF AEC2s (red, healthy; blue, IPF AEC2). (<bold>B</bold>) IFN activation score and expression of <italic>IFI27</italic> of AEC2s from healthy and IPF lungs (red, healthy; blue, IPF). (<bold>C</bold>) Violin plots of expression of mouse AEC2-2 signature genes in healthy and IPF AEC2s (red, healthy; blue, IPF AEC2). Violin plots of expression of AEC2-3 signature genes, including ER stress-related (<bold>D</bold>), claudin family (<bold>E</bold>), S100 family (<bold>F</bold>), and keratin family (<bold>G</bold>) in healthy and IPF AEC2s (red, healthy; blue, IPF). (<bold>H</bold>) UMAP showing three subsets of human AEC2s from healthy and IPF lungs. (<bold>I</bold>) AEC2 subset distribution in healthy and IPF AEC2s. Selected gene expression of AEC2 subsets from healthy and IPF lungs, <italic>SFTPC</italic> (<bold>J</bold>); <italic>IFI27</italic> (<bold>K</bold>); <italic>GAS6</italic> (<bold>L</bold>); and <italic>CLDN4</italic> (<bold>M</bold>). (<bold>N</bold>) HTII-280 (arrows) and CLDN4 co-staining (arrowheads) of human lung sections, scale bars 50 μm. (<bold>O</bold>) Quantitation of the percentage of HTII280+CLDN4+ cells in total HTII-280+ AEC2s in healthy and IPF lungs (<italic>n</italic> = 9–10, ****p &lt; 0.0001, by unpaired two-tailed Student’s <italic>t</italic>-test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-85415-fig7-v2.tif"/></fig><p>Several ER stress-related genes (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), claudin family genes (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), S100 family genes (<xref ref-type="fig" rid="fig7">Figure 7F</xref>), as well as keratin family genes (<xref ref-type="fig" rid="fig7">Figure 7G</xref>) were upregulated in IPF AEC2s which are the orthologous genes upregulated in the mouse subset AEC2-3. Among the keratin family genes that were upregulated in IPF lungs, KRT17 was most elevated compared to the low expression level in healthy AEC2s. This finding was consistent with the report that KRT17 expressing cells accumulated in IPF lungs (<xref ref-type="bibr" rid="bib1">Adams et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Habermann et al., 2020</xref>).</p><p>Next we asked if AEC2s from human lungs could be separated into different subsets, similar to the mouse AEC2s. Indeed, three clusters were readily recognized and overlapped well with AEC2s from healthy and IPF lungs (<xref ref-type="fig" rid="fig7">Figure 7H</xref>). While subset 1 and 2 clusters were predominate in healthy lungs, the subset 3 cluster mainly existed in IPF lungs (<xref ref-type="fig" rid="fig7">Figure 7I</xref>). Both subsets 1 and 2 expressed the AEC2 marker gene, <italic>SFTPC</italic> (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). Subset 2 and 3 cluster cells expressed IFN-induced gene, <italic>IFI27</italic> (<xref ref-type="fig" rid="fig7">Figure 7K</xref>), <italic>GAS6</italic> (<xref ref-type="fig" rid="fig7">Figure 7L</xref>), and <italic>CLDN</italic>4 (<xref ref-type="fig" rid="fig7">Figure 7M</xref>), which are the orthologous genes that were highly expressed in mouse AEC2 subsets AEC2-2 and AEC2-3 in injured mouse lungs (<xref ref-type="fig" rid="fig2">Figure 2G, H</xref>). Thus, the AEC2 subset classification also applies to human AEC2s.</p><p>To confirm our findings, we performed immunofluorescence staining of human lung sections for CLDN4 and HTII-280. As expected, there was a significant loss of HTII-280<sup>+</sup> AEC2s in IPF lungs (<xref ref-type="fig" rid="fig7">Figure 7N</xref>) consistent with our previous reports (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>; <xref ref-type="bibr" rid="bib48">Yao et al., 2021</xref>). Interestingly, the majority of remaining AEC2s in IPF lungs were CLDN4<sup>+</sup> while only a small portion of AEC2s in healthy lungs were CLDN4<sup>+</sup> (<xref ref-type="fig" rid="fig7">Figure 7N</xref>). We quantified the number of total HTII-280<sup>+</sup> AEC2s and HTII-280<sup>+</sup>CLDN4<sup>+</sup> AEC2s in multiple sections. The percentage of CLDN4<sup>+</sup>HTII-280<sup>+</sup> in total HTII-280<sup>+</sup> AEC2s was much higher in IPF lung sections than that of healthy lung sections (<xref ref-type="fig" rid="fig7">Figure 7O</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Lung aging showed the hallmarks of cellular aging including genomic instability, nutrient sensing aberrations, cell–cell communication impairment, mitochondrial abnormalities, aberrant proteostasis, stem cell exhaustion, and cellular senescence (<xref ref-type="bibr" rid="bib13">Cho and Stout-Delgado, 2020</xref>; <xref ref-type="bibr" rid="bib31">López-Otín et al., 2013</xref>; <xref ref-type="bibr" rid="bib34">Oliviero et al., 2022</xref>; <xref ref-type="bibr" rid="bib38">Rojas et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Thannickal, 2013</xref>). Alveolar epithelial progenitor cell dysfunction is an important pathogenic characteristic in lung aging and aging-associated lung fibrosis, IPF (<xref ref-type="bibr" rid="bib9">Chanda et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Cho and Stout-Delgado, 2020</xref>; <xref ref-type="bibr" rid="bib15">Cui et al., 2022</xref>; <xref ref-type="bibr" rid="bib29">Liang et al., 2022</xref>; <xref ref-type="bibr" rid="bib40">Selman and Pardo, 2020</xref>). In this study, we analyzed gene signatures and functional alterations of AEC2s with aging during lung injury to illustrate the impact of aging on lung epithelilum injury and repair. Our data demonstrate that aging augmented injury-related gene expression, while lung injury also elevated aging-related gene expression in AEC2s, resulting in a vicious cycle of genetic reprogramming that further impairs AEC2 functions.</p><p>The heterogeneity of lung epithelial cells has been examined in both mouse models and human lung diseases with scRNA-seq (<xref ref-type="bibr" rid="bib1">Adams et al., 2020</xref>; <xref ref-type="bibr" rid="bib8">Carraro et al., 2020</xref>; <xref ref-type="bibr" rid="bib17">Habermann et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Reyfman et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>). Most scRNA-seq analyses were performed with the inclusion of all cell types in the lung. In this study, we performed scRNA-seq with flow-enriched epithelial cells from bleomycin-injured young and aged mouse lungs, as well as lungs from IPF patients and healthy donors. This allowed us to deeply analyze the gene signature of AEC2s under the influence of both aging and injury. We identified three subsets of AEC2s. Subset AEC2-1 cells represent intact, homeostatic AEC2s and subsets AEC2-2 and AEC2-3 represent injured AEC2s.</p><p>The distribution of AEC2 subsets in the lung is influenced by aging. At baseline, over 80% of AEC2s are subset AEC2-1 in the young mouse lungs. However, old mouse lungs contain a lower percentage of subset AEC2-1 cells, intact AEC2, and more AEC2-2 and AEC2-3 cells, injured AEC2s relative to the cells from young mouse lungs, suggesting a chronic AEC2 injury and turnover in aged lungs despite no additional overt exogenous injury. This finding is consistent with a pro-inflammatory signature in aged lung (<xref ref-type="bibr" rid="bib2">Angelidis et al., 2019</xref>). During recovery after bleomycin injury, AEC2s in the aged lungs failed to transition effectively back from subsets AEC2-2 and AEC2-3 to subset AEC2-1 cells as occurred in the lungs of young mice. The failure of damaged AEC2s to revert back to intact AEC2s could be associated with impaired progenitor renewal of AEC2s in aged mouse lung. We have reported that AEC2s from aged mouse lungs had decreased renewal capacity relative to AEC2s from young mice due to downregulated sirtuin signaling in aged AEC2s (<xref ref-type="bibr" rid="bib29">Liang et al., 2022</xref>).</p><p>In human lungs, we found that AEC2s from healthy lungs have a similar gene signature to the subset AEC2-1 in mice that highly express canonical AEC2 marker genes and are the major AEC2 subset in uninjured lung. Interestingly, IPF AEC2s exhibited a similar gene signature to subsets AEC2-2 and AEC2-3 in injured old mouse lungs. These data suggest that the subset classification of AEC2s we employed in the mouse model has biologic relevance to human disease at least at the gene expression level.</p><p>Previous studies showed that CLDN4-expressing cells; KRT8, KRT17, and KRT19 expressing AEC2s acummulated in mouse lungs after injury and in human IPF lungs. These cells were identified as transitional AEC2s and could not effectively differentiate into AEC1s (<xref ref-type="bibr" rid="bib1">Adams et al., 2020</xref>; <xref ref-type="bibr" rid="bib24">Jiang et al., 2020b</xref>; <xref ref-type="bibr" rid="bib26">Kobayashi et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Strunz et al., 2020</xref>). The subset AEC2-3 we defined in this study should include the transitional AEC2s identified previously based on their elevated claudin family and keratin family gene expression. Our data further suggested that aging enhanced the gene expression of the aberrant AEC2s after lung injury. RNA trajectory analysis of the lineage differentiation potentials suggests that AEC2-3 cells were from subset AEC2-1 via subset AEC2-2. Interestingly, subset AEC2-3 also showed heterogeneity within the cluster, and some cells within this subset were further differentiated into AEC1 cells. However, there is no clear evidence showing dedifferentiation of AEC1 into subset AEC2-3. Careful lineage tracing studies are needed to confirm these transitions. Furthermore, with 3D organoid cultures, we demonstrated that the Cldn4+ subset AEC2-3 cells had impaired progenitor renewal. Our findings provide insights into understanding the role of aging in AEC2 cellular responses to lung injury and repair. It is interesting to speculate that subsets AEC2-2 and AEC2-3 cells may have an enhanced capacity to promote fibrogenesis and future studies are needed to address this hypothesis.</p><p>The observation that IPF AECs have a similar gene expression pattern to injured aged mouse AEC2s supports the longstanding concept that repetitive injury of AEC2 cells is a critical component of IPF pathogenesis. What remains a complete conundrum is what is the source of injury in IPF as no exogenous injuriant has ever been identified. The gene expression patterns we identified may yield some clues as how to pursue endogenous sources of injury that could be remediable. The bleomycin mouse model has been widely used as an animal model for human IPF. Our data indicate that bleomycin-injured aged mice might better represent aspects of human disease as it was suggested in a previous study by <xref ref-type="bibr" rid="bib18">Hecker et al., 2014</xref>.</p><p>In summary, we have performed comprehensive scRNA-seq analyses of lung alveolar epithelial cells in mouse and man under homeostatic conditions and following lung injury in both old and young mice and in human disease. We identified distinct AEC2 subsets following injury and examined the impact of aging on AEC2 injury and recovery. We uncovered a common theme in gene expression between injured aged mouse AEC2s and human IPF AEC2s. These data suggest that aging is a critical factor affecting AEC2s response to lung injury and their post injury recovery. Efforts to restore the genetic programs in AEC2s with pharmaceutical reagents might offer new opportunities for therapeutic approaches to aging-associated lung diseases such as IPF.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57Bl/6J</td><td align="left" valign="bottom">Jackson Laboratory</td><td align="left" valign="bottom">Strain #: 000664<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Bleomycin</td><td align="left" valign="bottom">Hospira, Lake Forest, IL 60045</td><td align="left" valign="bottom">NDC 61703-332-18</td><td align="left" valign="bottom">2.5 U/kg in vivo, mice</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mouse EpCAM<break/>clone G8.8 (rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Catalog # 118216<break/>RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1236471">AB_1236471</ext-link></td><td align="left" valign="bottom">Flow 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse CD24<break/>clone M1/69 (rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Catalog # 12-0242-82, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_467169">AB_467169</ext-link></td><td align="left" valign="bottom">Flow 1:50</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Sca-1 (Ly-6A/E)-<break/>clone D7 (rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Catalog # 17-5981-82, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_469487">AB_469487</ext-link></td><td align="left" valign="bottom">Flow 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mouse CD31 (PECAM-1) clone 390 (rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Catalog # 13-0311-85, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466421">AB_466421</ext-link></td><td align="left" valign="bottom">Flow 1:40</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mouse CD34<break/>clone RAM34 (rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Catalog # 13-0341-85, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466425">AB_466425</ext-link></td><td align="left" valign="bottom">Flow 1:16</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Mouse CD45<break/>clone 30-F11 (rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Catalog # 13-0451-85, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466447">AB_466447</ext-link></td><td align="left" valign="bottom">Flow 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human CD31<break/>clone WM59 (mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Clone WM59; RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_314327">AB_314327</ext-link></td><td align="left" valign="bottom">Flow 1:40</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human CD45<break/>clone WI30 (mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Catalog # 304016, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_314404">AB_314404</ext-link></td><td align="left" valign="bottom">Flow 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-human EpCAM clone 9C4 (mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Catalog # 324212, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_756086">AB_756086</ext-link></td><td align="left" valign="bottom">Flow 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-human Claudin 4<break/>IgG (rabbit polyclonal)</td><td align="left" valign="bottom">ProteinTech</td><td align="left" valign="bottom">16195-1-AP, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2082969">AB_2082969</ext-link></td><td align="left" valign="bottom">Flow 1:50; IF 1:200</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-HT2-280<break/>IgM (mouse monoclonal)</td><td align="left" valign="bottom">Terrace Biotech</td><td align="left" valign="bottom">TB-27AHT2-280, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2832931">AB_2832931</ext-link></td><td align="left" valign="bottom">Flow 1:60; IF 1:200</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>Sftpc</italic> _F</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGGTCCCAGGAGCCAGTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>Sftpc</italic>_R</td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAGCTGGCTTATAGGCCGTCAG</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>Pdpn_F</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">GCACCTCTGGTACCAACGCAGA</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">mouse <italic>Pdpn_R</italic></td><td align="left" valign="bottom">This paper</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom"><named-content content-type="sequence">TCTGAGGTTGCTGAGGTGGACAGT</named-content></td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">MLg2908, lung fibroblast (normal)</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">Catalog CCL-206</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Flow Jo</td><td align="left" valign="bottom">Tree Star</td><td align="left" valign="bottom">Version 9.9.6</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">RStudio</td><td align="left" valign="bottom">RStudio PBC</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_000432">SCR_000432</ext-link>, version 2022.07.2 build 576</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>, version 8.4.3</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Animals and study approval</title><p>All mouse maintenance and procedures were done under the guidance of the Cedars-Sinai Medical Center Institutional Animal Care and Use Committee (IACUC008529) in accordance with institutional and regulatory guidelines. All mice were housed in a pathogen-free facility at Cedars-Sinai. Eight- to 12-week-old (young) and 18- to 24-month-old (aged) wild-type C57Bl/6J mice were obtained from The Jackson Laboratory and housed in the institution facility at least 2 weeks before experiments.</p></sec><sec id="s4-2"><title>Information of human subjects, human lung tissue, and study approval</title><p>The use of human tissues for research was approved by the Institutional Review Board (IRB) of Cedars-Sinai and was under the guidelines outlined by the IRB (Pro00032727). Informed consent was obtained from each subject. The human samples used in the studies are age matched between IPF and healthy donors. The median age is 60 for healthy donors and 66 for IPF patients. We are aware to get the best age-matched samples within each experiment.</p></sec><sec id="s4-3"><title>Bleomycin instillation</title><p>Bleomycin instillation (2.5 U/kg) by intratracheal administration was described previously (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>).</p></sec><sec id="s4-4"><title>Mouse lung dissociation and flow cytometry</title><p>Mouse lung single-cell suspensions and the procedures of staining the cells for flow cytometry and data analysis were described previously (<xref ref-type="bibr" rid="bib3">Barkauskas et al., 2013</xref>; <xref ref-type="bibr" rid="bib10">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>). Flow cytometry was performed using a LSRFortessa flow cytometer and FACSAria III sorter (BD, San Jose, CA) and the data were analyzed using Flow Jo 9.9.6 software (Tree Star, Ashland, OR). Primary antibodies EpCAM-PE-Cy7 (clone G8.8, Catalog # 118216, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1236471">AB_1236471</ext-link>) were from BioLegend. CD24-PE (clone M1/69, Catalog # 12-0242-82, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_467169">AB_467169</ext-link>), Sca-1 (Ly-6A/E)-APC (clone D7, Catalog # 17-5981-82, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_469487">AB_469487</ext-link>), CD31 (PECAM-1) (clone 390, Catalog # 13-0311-85, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466421">AB_466421</ext-link>), CD34 (clone RAM34, Catalog # 13-0341-85, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466425">AB_466425</ext-link>), and CD45 (clone 30-F11, Catalog # 13-0451-85, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_466447">AB_466447</ext-link>) were all from eBioscience (San Diego, CA). Streptavidin-APC-Cy7 (catalog # 405208) was from BioLegend (San Diego, CA).</p></sec><sec id="s4-5"><title>Human lung dissociation and flow cytometry</title><p>Human lung single-cell isolation and flow cytometer analysis and sorting were performed as described previously (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>). Anti-human CD31 (clone WM59, Catalog # 303118, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2247932">AB_2247932</ext-link>), CD45 (clone WI30, Catalog # 304016, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_314404">AB_314404</ext-link>), and EpCAM (clone 9C4, Catalog # 324212, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_756086">AB_756086</ext-link>) were from BioLegend.</p></sec><sec id="s4-6"><title>Human lung section immunofluorescence staining</title><p>Cryosections and immunostaining were following standard protocols. Primary antibodies rabbit anti-Claudin 4 IgG polyclonal antibody (16195-1-AP, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2082969">AB_2082969</ext-link>, Proteintech) and mouse anti-HT2-280 IgM monoclonal antibody (TB-27AHT2-280, RRID <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2832931">AB_2832931</ext-link>, Terrace Biotech) were used and followed by fluorescence-labeled secondary antibodies.</p></sec><sec id="s4-7"><title>scRNA-seq and data analysis</title><p>scRNA-seq was performed in Genomics Core at Cedars-Sinai. Flow sorted human and mouse single cells were lysed, and mRNA was reverse transcribed and amplified as previously described (<xref ref-type="bibr" rid="bib30">Liu et al., 2021</xref>). The barcoded libraries were sequenced with NextSeq500 (Illumina, San Diego, CA) to obtain a sequencing depth of ~200K reads per cell.</p><p>Raw scRNA-seq data were aligned to human genome GRCh38 and mouse genome mm10 with Cell Ranger, respectively. Downstream quality control, normalization and visualization were performed with Seurat package (<xref ref-type="bibr" rid="bib7">Butler et al., 2018</xref>). For quality control, the output expression matrix from Cell Ranger was done based on number of genes detected in each cell, number of transcripts detected in each cell, and percentage of mitochondrial genes. The expression matrix was then normalized and visualized with UMAP. Bioinformatics analysis of scRNA-seq data was detailed in our recent report (<xref ref-type="bibr" rid="bib30">Liu et al., 2021</xref>). Silhouette analysis of <italic>k</italic>-means clustering was used to assess the separation distance between the resulting clusters. SCRAT was used to determine and envision high-dimensional metagene sets exhibited in AEC2 subsets as we described previously (<xref ref-type="bibr" rid="bib30">Liu et al., 2021</xref>; <xref ref-type="bibr" rid="bib46">Xie et al., 2018</xref>). IPA was performed as described previously (<xref ref-type="bibr" rid="bib30">Liu et al., 2021</xref>). The activation score reflects the sum of expression levels of a biological process (or pathway) related genes in each single cell, the results of each cluster cell were shown in Violin plots (<xref ref-type="bibr" rid="bib48">Yao et al., 2021</xref>). The genes in the biological process (or pathway) were downloaded from UniProt. RNA trajectory analysis was performed with Slingshot (<xref ref-type="bibr" rid="bib41">Street et al., 2018</xref>).</p></sec><sec id="s4-8"><title>RNA analysis</title><p>RNA was extracted from mouse AEC2s using TRIzol Reagent. For real-time PCR analysis, 0.5 μg total RNA was used for reverse transcription with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). One microliter cDNA was subjected to real-time PCR by using Power SYBR Green PCR Master Mix (Applied Biosystems) and the ABI 7500 Fast Real-Time PCR system (Applied Biosystems). The specific primers were designed based on cDNA sequences deposited in the GenBank database: mouse <italic>Sftpc</italic> (NM_011359.2), forward 5′-<named-content content-type="sequence">GCAGGTCCCAGGAGCCAGTTC</named-content>-3′ and reverse 5′-<named-content content-type="sequence">GGAGCTGGCTTATAGGCCGTCAG</named-content>-3′; mouse <italic>Pdpn</italic> (NM_010329.3), forward 5′-<named-content content-type="sequence">GCACCTCTGGTACCAACGCAGA</named-content>-3′ and reverse 5′-<named-content content-type="sequence">TCTGAGGTTGCTGAGGTGGACAGT</named-content>-3′.</p></sec><sec id="s4-9"><title>3D Matrigel culture of human and mouse AEC2s</title><p>Flow sorted mouse (EpCAM<sup>+</sup>CD31<sup>−</sup>CD34<sup>−</sup>CD45<sup>−</sup>CD24<sup>−</sup>Sca-1<sup>−</sup>) AEC2s (3 × 10<sup>3</sup>) were cultured in Matrigel/medium (1:1 in volume) mixture in the presence of lung fibroblasts MLg2908 cells (2 × 10<sup>5</sup>, Catalog CCL-206, ATCC, Manassas, VA) (<xref ref-type="bibr" rid="bib28">Liang et al., 2016</xref>). MLg2908 has been authenticated using STR profiling and tested free of mycoplasma contamination. Fresh medium with proper treatment was changed every other day. Colonies were visualized with a Zeiss Axiovert40 inverted fluorescent microscope (Carl Zeiss AG, Oberkochen, Germany). Number of colonies with a diameter of ≥50 µm were counted and CFE was determined by the number of colonies in each culture as a percentage of input epithelial cells at 12 days after plating. The treatments were repeated at least three times and similar results were obtained.</p></sec><sec id="s4-10"><title>Statistics</title><p>The statistical difference between groups in the bioinformatics analysis was calculated using the Wilcoxon signed-rank test. For the scRNA-seq data, the lowest p-value calculated in Seurat was p &lt; 2.2e−10<sup>−16</sup>. For cell treatment data, the statistical difference between groups was calculated using Prism (version 8.4.3) (GraphPad, San Diego, CA). Data are expressed as the mean ± standard error of the mean. Differences in measured variables between experimental and control group were assessed by using Student’s <italic>t</italic>-tests. Results were considered statistically significant at p &lt; 0.05.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>Senior editor, <italic>eLife</italic></p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Investigation</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Software, Formal analysis, Investigation, Visualization</p></fn><fn fn-type="con" id="con9"><p>Resources, Data curation, Software, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Resources, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Resources, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Information of human subjects, human lung tissue, and study approval. The use of human tissues for research was approved by the Institutional Review Board (IRB) of Cedars-Sinai and was under the guidelines outlined by the IRB (Pro00032727). Informed consent was obtained from each subject. The human samples used in the studies are age matched between IPF and healthy donors. The median age is 60 for healthy donors and 66 for IPF patients. We are aware to get the best age-matched samples within each experiment.</p></fn><fn fn-type="other"><p>Animals and study approval. All mouse maintenance and procedures were done under the guidance of the Cedars-Sinai Medical Center Institutional Animal Care and Use Committee (IACUC008529) in accordance with institutional and regulatory guidelines. All mice were housed in a pathogen-free facility at Cedars-Sinai. Eight- to 12-week-old (young) and 18- to 24-month-old (aged) wild-type C57Bl/6J mice were obtained from The Jackson Laboratory and housed in the institution facility at least 2 weeks before experiments.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Significantly enriched canonical pathways in AEC2 subsets using Ingenuity Pathway Analysis (IPA).</title><p>(<bold>a</bold>) Ingenuity pathway analysis showing activation <italic>Z</italic>-scores for selected pathways in AEC2-2 compared to AEC2-1. (<bold>b</bold>) Ingenuity pathway analysis showing activation <italic>Z</italic>-scores for selected pathways in AEC2-3 compared to AEC2-1.</p></caption><media xlink:href="elife-85415-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-85415-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The raw datasets of single-cell RNA-seq of mouse and human epithelial cells are under GSE157995 and GSE157996, respectively.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Single-cell RNA-sequencing of bleomycin-injured young and old mice</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157995">GSE157995</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Single-cell RNA-sequencing of human lung Lin-EpCAM+ cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157996">GSE157996</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Taghavifar</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Single-cell RNA-sequencing of mouse and human lung Lin-EpCAM+ cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157997">GSE157997</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank the members of Noble and Jiang laboratory for support and helpful discussion during the course of the study. This work was supported by National Institutes of Health grants R35-HL150829, R01-HL060539, R01-AI052201 (PWN), and R01-HL122068 (DJ and PWN), R0-1AG078655 (JL and PWN) and P01-HL108793 (PWN and DJ). We thank Dr. L Dobbs of UCSF providing antibodies for the study. The authors thank Genomics Core and Flow Cytometry Core at Cedars for their technical support. Funding information: This work was supported by NIH grants R0-1AG078655, R35-HL150829, R01-HL060539, R01-AI052201, R01-HL122068, and P01-HL108793. Data availability: The single-cell RNA-seq datasets and analysis code files are deposited in GEO and Github, respectively.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>TS</given-names></name><name><surname>Schupp</surname><given-names>JC</given-names></name><name><surname>Poli</surname><given-names>S</given-names></name><name><surname>Ayaub</surname><given-names>EA</given-names></name><name><surname>Neumark</surname><given-names>N</given-names></name><name><surname>Ahangari</surname><given-names>F</given-names></name><name><surname>Chu</surname><given-names>SG</given-names></name><name><surname>Raby</surname><given-names>BA</given-names></name><name><surname>DeIuliis</surname><given-names>G</given-names></name><name><surname>Januszyk</surname><given-names>M</given-names></name><name><surname>Duan</surname><given-names>Q</given-names></name><name><surname>Arnett</surname><given-names>HA</given-names></name><name><surname>Siddiqui</surname><given-names>A</given-names></name><name><surname>Washko</surname><given-names>GR</given-names></name><name><surname>Homer</surname><given-names>R</given-names></name><name><surname>Yan</surname><given-names>X</given-names></name><name><surname>Rosas</surname><given-names>IO</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA-Seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba1983</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1983</pub-id><pub-id pub-id-type="pmid">32832599</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angelidis</surname><given-names>I</given-names></name><name><surname>Simon</surname><given-names>LM</given-names></name><name><surname>Fernandez</surname><given-names>IE</given-names></name><name><surname>Strunz</surname><given-names>M</given-names></name><name><surname>Mayr</surname><given-names>CH</given-names></name><name><surname>Greiffo</surname><given-names>FR</given-names></name><name><surname>Tsitsiridis</surname><given-names>G</given-names></name><name><surname>Ansari</surname><given-names>M</given-names></name><name><surname>Graf</surname><given-names>E</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Nagendran</surname><given-names>M</given-names></name><name><surname>Desai</surname><given-names>T</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Schiller</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An atlas of the aging lung mapped by single cell transcriptomics and deep tissue proteomics</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>963</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08831-9</pub-id><pub-id pub-id-type="pmid">30814501</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Cronce</surname><given-names>MJ</given-names></name><name><surname>Rackley</surname><given-names>CR</given-names></name><name><surname>Bowie</surname><given-names>EJ</given-names></name><name><surname>Keene</surname><given-names>DR</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Type 2 alveolar cells are stem cells in adult lung</article-title><source>The Journal of Clinical Investigation</source><volume>123</volume><fpage>3025</fpage><lpage>3036</lpage><pub-id pub-id-type="doi">10.1172/JCI68782</pub-id><pub-id pub-id-type="pmid">23921127</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borok</surname><given-names>Z</given-names></name><name><surname>Horie</surname><given-names>M</given-names></name><name><surname>Flodby</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ganesh</surname><given-names>S</given-names></name><name><surname>Firth</surname><given-names>AL</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Beers</surname><given-names>MF</given-names></name><name><surname>Lee</surname><given-names>AS</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>Grp78</italic> loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>201</volume><fpage>198</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1164/rccm.201902-0451OC</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueno</surname><given-names>M</given-names></name><name><surname>Brands</surname><given-names>J</given-names></name><name><surname>Voltz</surname><given-names>L</given-names></name><name><surname>Fiedler</surname><given-names>K</given-names></name><name><surname>Mays</surname><given-names>B</given-names></name><name><surname>St Croix</surname><given-names>C</given-names></name><name><surname>Sembrat</surname><given-names>J</given-names></name><name><surname>Mallampalli</surname><given-names>RK</given-names></name><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ATF3 represses PINK1 Gene transcription in lung epithelial cells to control mitochondrial homeostasis</article-title><source>Aging Cell</source><volume>17</volume><elocation-id>e12720</elocation-id><pub-id pub-id-type="doi">10.1111/acel.12720</pub-id><pub-id pub-id-type="pmid">29363258</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burman</surname><given-names>A</given-names></name><name><surname>Tanjore</surname><given-names>H</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Endoplasmic reticulum stress in pulmonary fibrosis</article-title><source>Matrix Biology</source><volume>68–69</volume><fpage>355</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1016/j.matbio.2018.03.015</pub-id><pub-id pub-id-type="pmid">29567124</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carraro</surname><given-names>G</given-names></name><name><surname>Mulay</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Konda</surname><given-names>B</given-names></name><name><surname>Petrov</surname><given-names>M</given-names></name><name><surname>Lafkas</surname><given-names>D</given-names></name><name><surname>Arron</surname><given-names>JR</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>McQualter</surname><given-names>JL</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell reconstruction of human basal cell diversity in normal and idiopathic pulmonary fibrosis lungs</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>202</volume><fpage>1540</fpage><lpage>1550</lpage><pub-id pub-id-type="doi">10.1164/rccm.201904-0792OC</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>D</given-names></name><name><surname>Rehan</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>SR</given-names></name><name><surname>Dsouza</surname><given-names>KG</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bernard</surname><given-names>K</given-names></name><name><surname>Kurundkar</surname><given-names>D</given-names></name><name><surname>Memula</surname><given-names>V</given-names></name><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Mobley</surname><given-names>JA</given-names></name><name><surname>Benavides</surname><given-names>GA</given-names></name><name><surname>Darley-Usmar</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Zmijewski</surname><given-names>JW</given-names></name><name><surname>Deshane</surname><given-names>JS</given-names></name><name><surname>De Langhe</surname><given-names>S</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mesenchymal stromal cell aging impairs the self-organizing capacity of lung alveolar epithelial stem cells</article-title><source>eLife</source><volume>10</volume><elocation-id>e68049</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.68049</pub-id><pub-id pub-id-type="pmid">34528872</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Brockway</surname><given-names>BL</given-names></name><name><surname>Rackley</surname><given-names>CR</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>CF</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Airway epithelial progenitors are region specific and show differential responses to bleomycin-induced lung injury</article-title><source>Stem Cells</source><volume>30</volume><fpage>1948</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.1002/stem.1150</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Childs</surname><given-names>BG</given-names></name><name><surname>Durik</surname><given-names>M</given-names></name><name><surname>Baker</surname><given-names>DJ</given-names></name><name><surname>van Deursen</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cellular senescence in aging and age-related disease: from mechanisms to therapy</article-title><source>Nature Medicine</source><volume>21</volume><fpage>1424</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1038/nm.4000</pub-id><pub-id pub-id-type="pmid">26646499</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilosi</surname><given-names>M</given-names></name><name><surname>Carloni</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>A</given-names></name><name><surname>Poletti</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema</article-title><source>Translational Research</source><volume>162</volume><fpage>156</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2013.06.004</pub-id><pub-id pub-id-type="pmid">23831269</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>SJ</given-names></name><name><surname>Stout-Delgado</surname><given-names>HW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Aging and lung disease</article-title><source>Annual Review of Physiology</source><volume>82</volume><fpage>433</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021119-034610</pub-id><pub-id pub-id-type="pmid">31730381</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>JE</given-names></name><name><surname>Tsagkogeorga</surname><given-names>G</given-names></name><name><surname>Yanagita</surname><given-names>M</given-names></name><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Han</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration</article-title><source>Cell Stem Cell</source><volume>27</volume><fpage>366</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2020.06.020</pub-id><pub-id pub-id-type="pmid">32750316</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>N</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Dey</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>RM</given-names></name><name><surname>Antony</surname><given-names>VB</given-names></name><name><surname>Sanders</surname><given-names>YY</given-names></name><name><surname>Adams</surname><given-names>TS</given-names></name><name><surname>Gomez</surname><given-names>JL</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Kaminski</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>CD38 mediates lung fibrosis by promoting alveolar epithelial cell aging</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>206</volume><fpage>459</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1164/rccm.202109-2151OC</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>TJ</given-names></name><name><surname>Brownfield</surname><given-names>DG</given-names></name><name><surname>Krasnow</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Alveolar progenitor and stem cells in lung development, renewal and cancer</article-title><source>Nature</source><volume>507</volume><fpage>190</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1038/nature12930</pub-id><pub-id pub-id-type="pmid">24499815</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habermann</surname><given-names>AC</given-names></name><name><surname>Gutierrez</surname><given-names>AJ</given-names></name><name><surname>Bui</surname><given-names>LT</given-names></name><name><surname>Yahn</surname><given-names>SL</given-names></name><name><surname>Winters</surname><given-names>NI</given-names></name><name><surname>Calvi</surname><given-names>CL</given-names></name><name><surname>Peter</surname><given-names>L</given-names></name><name><surname>Chung</surname><given-names>MI</given-names></name><name><surname>Taylor</surname><given-names>CJ</given-names></name><name><surname>Jetter</surname><given-names>C</given-names></name><name><surname>Raju</surname><given-names>L</given-names></name><name><surname>Roberson</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>G</given-names></name><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Sucre</surname><given-names>JMS</given-names></name><name><surname>Richmond</surname><given-names>BW</given-names></name><name><surname>Serezani</surname><given-names>AP</given-names></name><name><surname>McDonnell</surname><given-names>WJ</given-names></name><name><surname>Mallal</surname><given-names>SB</given-names></name><name><surname>Bacchetta</surname><given-names>MJ</given-names></name><name><surname>Loyd</surname><given-names>JE</given-names></name><name><surname>Shaver</surname><given-names>CM</given-names></name><name><surname>Ware</surname><given-names>LB</given-names></name><name><surname>Bremner</surname><given-names>R</given-names></name><name><surname>Walia</surname><given-names>R</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Banovich</surname><given-names>NE</given-names></name><name><surname>Kropski</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaba1972</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aba1972</pub-id><pub-id pub-id-type="pmid">32832598</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecker</surname><given-names>L</given-names></name><name><surname>Logsdon</surname><given-names>NJ</given-names></name><name><surname>Kurundkar</surname><given-names>D</given-names></name><name><surname>Kurundkar</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>K</given-names></name><name><surname>Hock</surname><given-names>T</given-names></name><name><surname>Meldrum</surname><given-names>E</given-names></name><name><surname>Sanders</surname><given-names>YY</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance</article-title><source>Science Translational Medicine</source><volume>6</volume><elocation-id>231ra47</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3008182</pub-id><pub-id pub-id-type="pmid">24718857</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hecker</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>314</volume><fpage>L642</fpage><lpage>L653</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00275.2017</pub-id><pub-id pub-id-type="pmid">29351446</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>BLM</given-names></name><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Epstein</surname><given-names>JA</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Hsia</surname><given-names>CCW</given-names></name><name><surname>Niklason</surname><given-names>L</given-names></name><name><surname>Calle</surname><given-names>E</given-names></name><name><surname>Le</surname><given-names>A</given-names></name><name><surname>Randell</surname><given-names>SH</given-names></name><name><surname>Rock</surname><given-names>J</given-names></name><name><surname>Snitow</surname><given-names>M</given-names></name><name><surname>Krummel</surname><given-names>M</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Vu</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>ES</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function</article-title><source>Cell Stem Cell</source><volume>15</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2014.07.012</pub-id><pub-id pub-id-type="pmid">25105578</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>KY</given-names></name><name><surname>Petretto</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cross-species integration of single-cell RNA-Seq resolved alveolar-epithelial transitional states in idiopathic pulmonary fibrosis</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>321</volume><fpage>L491</fpage><lpage>L506</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00594.2020</pub-id><pub-id pub-id-type="pmid">34132117</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Luckhardt</surname><given-names>T</given-names></name><name><surname>Antony</surname><given-names>V</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Carter</surname><given-names>AB</given-names></name><name><surname>Thannickal</surname><given-names>VJ</given-names></name><name><surname>Liu</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serpine 1 induces alveolar type II cell senescence through activating p53-p21-Rb pathway in fibrotic lung disease</article-title><source>Aging Cell</source><volume>16</volume><fpage>1114</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1111/acel.12643</pub-id><pub-id pub-id-type="pmid">28722352</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2020">2020a</year><source>Stem Cells and Progenitor Cells in Interstitial Lung Disease</source><publisher-name>Elsevier</publisher-name></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Gil de Rubio</surname><given-names>R</given-names></name><name><surname>Hrycaj</surname><given-names>SM</given-names></name><name><surname>Gurczynski</surname><given-names>SJ</given-names></name><name><surname>Riemondy</surname><given-names>KA</given-names></name><name><surname>Moore</surname><given-names>BB</given-names></name><name><surname>Omary</surname><given-names>MB</given-names></name><name><surname>Ridge</surname><given-names>KM</given-names></name><name><surname>Zemans</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Ineffectual type 2-to-type 1 alveolar epithelial cell differentiation in idiopathic pulmonary fibrosis: persistence of the KRT8(Hi) transitional state</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>201</volume><fpage>1443</fpage><lpage>1447</lpage><pub-id pub-id-type="doi">10.1164/rccm.201909-1726LE</pub-id><pub-id pub-id-type="pmid">32073903</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Verma</surname><given-names>R</given-names></name><name><surname>Jablonski</surname><given-names>RP</given-names></name><name><surname>Chen</surname><given-names>CI</given-names></name><name><surname>Cheresh</surname><given-names>P</given-names></name><name><surname>Markov</surname><given-names>NS</given-names></name><name><surname>Reyfman</surname><given-names>PA</given-names></name><name><surname>McQuattie-Pimentel</surname><given-names>AC</given-names></name><name><surname>Sichizya</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Piseaux-Aillon</surname><given-names>R</given-names></name><name><surname>Kirchenbuechler</surname><given-names>D</given-names></name><name><surname>Flozak</surname><given-names>AS</given-names></name><name><surname>Gottardi</surname><given-names>CJ</given-names></name><name><surname>Cuda</surname><given-names>CM</given-names></name><name><surname>Perlman</surname><given-names>H</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Kamp</surname><given-names>DW</given-names></name><name><surname>Budinger</surname><given-names>GRS</given-names></name><name><surname>Misharin</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages</article-title><source>The European Respiratory Journal</source><volume>55</volume><elocation-id>1900646</elocation-id><pub-id pub-id-type="doi">10.1183/13993003.00646-2019</pub-id><pub-id pub-id-type="pmid">31601718</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Tata</surname><given-names>A</given-names></name><name><surname>Konkimalla</surname><given-names>A</given-names></name><name><surname>Katsura</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>RF</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Banovich</surname><given-names>NE</given-names></name><name><surname>Kropski</surname><given-names>JA</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>934</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0542-8</pub-id><pub-id pub-id-type="pmid">32661339</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Ward</surname><given-names>WO</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Vallanat</surname><given-names>B</given-names></name><name><surname>Darlington</surname><given-names>GJ</given-names></name><name><surname>Han</surname><given-names>ES</given-names></name><name><surname>Laguna</surname><given-names>JC</given-names></name><name><surname>DeFord</surname><given-names>JH</given-names></name><name><surname>Papaconstantinou</surname><given-names>J</given-names></name><name><surname>Selman</surname><given-names>C</given-names></name><name><surname>Corton</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Meta-analysis of gene expression in the mouse liver reveals biomarkers associated with inflammation increased early during aging</article-title><source>Mechanisms of Ageing and Development</source><volume>133</volume><fpage>467</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2012.05.006</pub-id><pub-id pub-id-type="pmid">22704917</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Geng</surname><given-names>Y</given-names></name><name><surname>Kurkciyan</surname><given-names>A</given-names></name><name><surname>Mena</surname><given-names>JM</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1285</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1038/nm.4192</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Taghavifar</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>N</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Kulur</surname><given-names>V</given-names></name><name><surname>Dai</surname><given-names>K</given-names></name><name><surname>Burman</surname><given-names>A</given-names></name><name><surname>Rowan</surname><given-names>SC</given-names></name><name><surname>Weigt</surname><given-names>SS</given-names></name><name><surname>Belperio</surname><given-names>J</given-names></name><name><surname>Stripp</surname><given-names>B</given-names></name><name><surname>Parks</surname><given-names>WC</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The Zip8/Sirt1 axis regulates alveolar progenitor cell renewal in aging and idiopathic pulmonary fibrosis</article-title><source>The Journal of Clinical Investigation</source><volume>132</volume><elocation-id>e157338</elocation-id><pub-id pub-id-type="doi">10.1172/JCI157338</pub-id><pub-id pub-id-type="pmid">35389887</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Rowan</surname><given-names>SC</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Deng</surname><given-names>N</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Burman</surname><given-names>A</given-names></name><name><surname>Parimon</surname><given-names>T</given-names></name><name><surname>Borok</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Parks</surname><given-names>WC</given-names></name><name><surname>Hogaboam</surname><given-names>CM</given-names></name><name><surname>Weigt</surname><given-names>SS</given-names></name><name><surname>Belperio</surname><given-names>J</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Categorization of lung mesenchymal cells in development and fibrosis</article-title><source>IScience</source><volume>24</volume><elocation-id>102551</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2021.102551</pub-id><pub-id pub-id-type="pmid">34151224</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Blasco</surname><given-names>MA</given-names></name><name><surname>Partridge</surname><given-names>L</given-names></name><name><surname>Serrano</surname><given-names>M</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The hallmarks of aging</article-title><source>Cell</source><volume>153</volume><fpage>1194</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.05.039</pub-id><pub-id pub-id-type="pmid">23746838</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McQuattie-Pimentel</surname><given-names>AC</given-names></name><name><surname>Ren</surname><given-names>Z</given-names></name><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Stoeger</surname><given-names>T</given-names></name><name><surname>Chi</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Sichizya</surname><given-names>L</given-names></name><name><surname>Aillon</surname><given-names>RP</given-names></name><name><surname>Chen</surname><given-names>CI</given-names></name><name><surname>Soberanes</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Reyfman</surname><given-names>PA</given-names></name><name><surname>Walter</surname><given-names>JM</given-names></name><name><surname>Anekalla</surname><given-names>KR</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Helmin</surname><given-names>KA</given-names></name><name><surname>Runyan</surname><given-names>CE</given-names></name><name><surname>Abdala-Valencia</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>K</given-names></name><name><surname>Meliton</surname><given-names>AY</given-names></name><name><surname>Winter</surname><given-names>DR</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Mutlu</surname><given-names>GM</given-names></name><name><surname>Bharat</surname><given-names>A</given-names></name><name><surname>Perlman</surname><given-names>H</given-names></name><name><surname>Gottardi</surname><given-names>CJ</given-names></name><name><surname>Ridge</surname><given-names>KM</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>Sznajder</surname><given-names>JI</given-names></name><name><surname>Balch</surname><given-names>WE</given-names></name><name><surname>Singer</surname><given-names>BD</given-names></name><name><surname>Misharin</surname><given-names>AV</given-names></name><name><surname>Budinger</surname><given-names>GRS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The lung microenvironment shapes a dysfunctional response of alveolar macrophages in aging</article-title><source>The Journal of Clinical Investigation</source><volume>131</volume><elocation-id>e140299</elocation-id><pub-id pub-id-type="doi">10.1172/JCI140299</pub-id><pub-id pub-id-type="pmid">33586677</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Barkauskas</surname><given-names>CE</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Pulmonary fibrosis: patterns and perpetrators</article-title><source>Journal of Clinical Investigation</source><volume>122</volume><fpage>2756</fpage><lpage>2762</lpage><pub-id pub-id-type="doi">10.1172/JCI60323</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliviero</surname><given-names>G</given-names></name><name><surname>Kovalchuk</surname><given-names>S</given-names></name><name><surname>Rogowska-Wrzesinska</surname><given-names>A</given-names></name><name><surname>Schwämmle</surname><given-names>V</given-names></name><name><surname>Jensen</surname><given-names>ON</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Distinct and diverse chromatin proteomes of ageing mouse organs reveal protein signatures that correlate with physiological functions</article-title><source>eLife</source><volume>11</volume><elocation-id>e73524</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.73524</pub-id><pub-id pub-id-type="pmid">35259090</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghu</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>SY</given-names></name><name><surname>Hou</surname><given-names>Q</given-names></name><name><surname>Yeh</surname><given-names>WS</given-names></name><name><surname>Collard</surname><given-names>HR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old</article-title><source>European Respiratory Journal</source><volume>48</volume><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1183/13993003.01653-2015</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyfman</surname><given-names>PA</given-names></name><name><surname>Walter</surname><given-names>JM</given-names></name><name><surname>Joshi</surname><given-names>N</given-names></name><name><surname>Anekalla</surname><given-names>KR</given-names></name><name><surname>McQuattie-Pimentel</surname><given-names>AC</given-names></name><name><surname>Chiu</surname><given-names>S</given-names></name><name><surname>Fernandez</surname><given-names>R</given-names></name><name><surname>Akbarpour</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>CI</given-names></name><name><surname>Ren</surname><given-names>Z</given-names></name><name><surname>Verma</surname><given-names>R</given-names></name><name><surname>Abdala-Valencia</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>K</given-names></name><name><surname>Chi</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Gonzalez-Gonzalez</surname><given-names>FJ</given-names></name><name><surname>Soberanes</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Williams</surname><given-names>KJN</given-names></name><name><surname>Flozak</surname><given-names>AS</given-names></name><name><surname>Nicholson</surname><given-names>TT</given-names></name><name><surname>Morgan</surname><given-names>VK</given-names></name><name><surname>Winter</surname><given-names>DR</given-names></name><name><surname>Hinchcliff</surname><given-names>M</given-names></name><name><surname>Hrusch</surname><given-names>CL</given-names></name><name><surname>Guzy</surname><given-names>RD</given-names></name><name><surname>Bonham</surname><given-names>CA</given-names></name><name><surname>Sperling</surname><given-names>AI</given-names></name><name><surname>Bag</surname><given-names>R</given-names></name><name><surname>Hamanaka</surname><given-names>RB</given-names></name><name><surname>Mutlu</surname><given-names>GM</given-names></name><name><surname>Yeldandi</surname><given-names>AV</given-names></name><name><surname>Marshall</surname><given-names>SA</given-names></name><name><surname>Shilatifard</surname><given-names>A</given-names></name><name><surname>Amaral</surname><given-names>LAN</given-names></name><name><surname>Perlman</surname><given-names>H</given-names></name><name><surname>Sznajder</surname><given-names>JI</given-names></name><name><surname>Argento</surname><given-names>AC</given-names></name><name><surname>Gillespie</surname><given-names>CT</given-names></name><name><surname>Dematte</surname><given-names>J</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Singer</surname><given-names>BD</given-names></name><name><surname>Ridge</surname><given-names>KM</given-names></name><name><surname>Lam</surname><given-names>AP</given-names></name><name><surname>Bharat</surname><given-names>A</given-names></name><name><surname>Bhorade</surname><given-names>SM</given-names></name><name><surname>Gottardi</surname><given-names>CJ</given-names></name><name><surname>Budinger</surname><given-names>GRS</given-names></name><name><surname>Misharin</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>199</volume><fpage>1517</fpage><lpage>1536</lpage><pub-id pub-id-type="doi">10.1164/rccm.201712-2410OC</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemondy</surname><given-names>KA</given-names></name><name><surname>Jansing</surname><given-names>NL</given-names></name><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Redente</surname><given-names>EF</given-names></name><name><surname>Gillen</surname><given-names>AE</given-names></name><name><surname>Fu</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>AJ</given-names></name><name><surname>Spence</surname><given-names>JR</given-names></name><name><surname>Gerber</surname><given-names>AN</given-names></name><name><surname>Hesselberth</surname><given-names>JR</given-names></name><name><surname>Zemans</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell RNA sequencing identifies TGF-β as a key regenerative cue following LPS-induced lung injury</article-title><source>JCI Insight</source><volume>5</volume><elocation-id>e123637</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.123637</pub-id><pub-id pub-id-type="pmid">30913038</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>M</given-names></name><name><surname>Mora</surname><given-names>AL</given-names></name><name><surname>Kapetanaki</surname><given-names>M</given-names></name><name><surname>Weathington</surname><given-names>N</given-names></name><name><surname>Gladwin</surname><given-names>M</given-names></name><name><surname>Eickelberg</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Aging and lung disease</article-title><source>Annals of the American Thoracic Society</source><volume>12</volume><fpage>S222</fpage><lpage>S227</lpage></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>JL</given-names></name><name><surname>Rowe</surname><given-names>JH</given-names></name><name><surname>Garcia-de-Alba</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>CF</given-names></name><name><surname>Sharpe</surname><given-names>AH</given-names></name><name><surname>Haigis</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The aging lung: physiology, disease, and immunity</article-title><source>Cell</source><volume>184</volume><fpage>1990</fpage><lpage>2019</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.03.005</pub-id><pub-id pub-id-type="pmid">33811810</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Pardo</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis</article-title><source>Cellular Signalling</source><volume>66</volume><elocation-id>109482</elocation-id><pub-id pub-id-type="doi">10.1016/j.cellsig.2019.109482</pub-id><pub-id pub-id-type="pmid">31760172</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>K</given-names></name><name><surname>Risso</surname><given-names>D</given-names></name><name><surname>Fletcher</surname><given-names>RB</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Ngai</surname><given-names>J</given-names></name><name><surname>Yosef</surname><given-names>N</given-names></name><name><surname>Purdom</surname><given-names>E</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Slingshot: cell lineage and pseudotime inference for single-cell Transcriptomics</article-title><source>BMC Genomics</source><volume>19</volume><elocation-id>477</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-018-4772-0</pub-id><pub-id pub-id-type="pmid">29914354</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strunz</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>LM</given-names></name><name><surname>Ansari</surname><given-names>M</given-names></name><name><surname>Kathiriya</surname><given-names>JJ</given-names></name><name><surname>Angelidis</surname><given-names>I</given-names></name><name><surname>Mayr</surname><given-names>CH</given-names></name><name><surname>Tsidiridis</surname><given-names>G</given-names></name><name><surname>Lange</surname><given-names>M</given-names></name><name><surname>Mattner</surname><given-names>LF</given-names></name><name><surname>Yee</surname><given-names>M</given-names></name><name><surname>Ogar</surname><given-names>P</given-names></name><name><surname>Sengupta</surname><given-names>A</given-names></name><name><surname>Kukhtevich</surname><given-names>I</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Voss</surname><given-names>C</given-names></name><name><surname>Stoeger</surname><given-names>T</given-names></name><name><surname>Neumann</surname><given-names>JHL</given-names></name><name><surname>Hilgendorff</surname><given-names>A</given-names></name><name><surname>Behr</surname><given-names>J</given-names></name><name><surname>O’Reilly</surname><given-names>M</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Burgstaller</surname><given-names>G</given-names></name><name><surname>Königshoff</surname><given-names>M</given-names></name><name><surname>Chapman</surname><given-names>HA</given-names></name><name><surname>Theis</surname><given-names>FJ</given-names></name><name><surname>Schiller</surname><given-names>HB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3559</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17358-3</pub-id><pub-id pub-id-type="pmid">32678092</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thannickal</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanistic links between aging and lung fibrosis</article-title><source>Biogerontology</source><volume>14</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1007/s10522-013-9451-6</pub-id><pub-id pub-id-type="pmid">23929205</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watson</surname><given-names>JK</given-names></name><name><surname>Sanders</surname><given-names>P</given-names></name><name><surname>Dunmore</surname><given-names>R</given-names></name><name><surname>Rosignoli</surname><given-names>G</given-names></name><name><surname>Julé</surname><given-names>Y</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name><name><surname>May</surname><given-names>R</given-names></name><name><surname>Clarke</surname><given-names>D</given-names></name><name><surname>Finch</surname><given-names>DK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distal lung epithelial progenitor cell function declines with age</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>10490</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-66966-y</pub-id><pub-id pub-id-type="pmid">32591591</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Bin</surname><given-names>E</given-names></name><name><surname>Wei</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells</article-title><source>Cell</source><volume>180</volume><fpage>107</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.11.027</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>N</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Taghavifar</surname><given-names>F</given-names></name><name><surname>Geng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Kulur</surname><given-names>V</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Stripp</surname><given-names>B</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell deconvolution of fibroblast heterogeneity in mouse pulmonary fibrosis</article-title><source>Cell Reports</source><volume>22</volume><fpage>3625</fpage><lpage>3640</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.010</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Sridharan</surname><given-names>A</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Wikenheiser-Brokamp</surname><given-names>KA</given-names></name><name><surname>Perl</surname><given-names>A-KT</given-names></name><name><surname>Funari</surname><given-names>VA</given-names></name><name><surname>Gokey</surname><given-names>JJ</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name><name><surname>Whitsett</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis</article-title><source>JCI Insight</source><volume>1</volume><elocation-id>e90558</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.90558</pub-id><pub-id pub-id-type="pmid">27942595</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Guan</surname><given-names>X</given-names></name><name><surname>Carraro</surname><given-names>G</given-names></name><name><surname>Parimon</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Mulay</surname><given-names>A</given-names></name><name><surname>Soukiasian</surname><given-names>HJ</given-names></name><name><surname>David</surname><given-names>G</given-names></name><name><surname>Weigt</surname><given-names>SS</given-names></name><name><surname>Belperio</surname><given-names>JA</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Stripp</surname><given-names>BR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>203</volume><fpage>707</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1164/rccm.202004-1274OC</pub-id><pub-id pub-id-type="pmid">32991815</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85415.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kraft</surname><given-names>Monica</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>These findings demonstrate the relationship between lung injury, aging, and lung fibrosis with strong evidence that aging modulates the response to lung injury and wound healing. This work furthers our understanding of fibrosis in humans, where idiopathic pulmonary fibrosis occurs most commonly at an advanced age.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85415.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kraft</surname><given-names>Monica</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Thannickal</surname><given-names>Victor J</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04vmvtb21</institution-id><institution>Tulane University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Reciprocal interactions between alveolar progenitor dysfunction and aging promote lung fibrosis&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Victor J Thannickal (Reviewer #1).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) With regard to the intermediate &quot;transitional&quot; states, the authors might consider performing RNA trajectory analysis to better define the dynamic changes and relationship between transcriptional states. For example, do the presumed transitional cells that express CLDN4 and keratin isoforms derive from healthy (young) AECs, or is it possible that AEC1 de-differentiation gives rise to these aberrant intermediate states? How does aging shift the trajectories of AECs in response to lung injury?</p><p>2) The identification of 3 distinct sub-types of AEC2s, which shift w/age and in bleo-injury is of interest and may yield future targetable genes for a range of age- or injury-related processes. The lack of proof-of-concept or mechanisms in terms of demonstrating that the 3 sub-types have differential roles in promoting (or stopping) lung fibrosis confers a descriptive status to this manuscript. However, if the goal of this manuscript is to present initial single-cell findings to the public using mouse and human samples, then what is presented is sufficient.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors employ single cell RNA sequencing of isolated alveolar type 2 cells (AEC2) to identify three clustered subsets that are influenced by age and lung injury. A synergistic effect of aging and lung injury contributed to impaired AEC2 recovery in aged mice after injury. Additionally, AEC2s from human idiopathic pulmonary fibrosis (IPF) revealed a similar transcriptomic signature to AEC2 subsets from bleomycin injured lungs from old mice. The studies are well done and provide new insights into how aging modulates the lung injury response in AECs.</p><p>With regard to the intermediate &quot;transitional&quot; states, the authors might consider performing RNA trajectory analysis to better define the dynamic changes and relationship between transcriptional states. For example, do the presumed transitional cells that express CLDN4 and keratin isoforms derive from healthy (young) AECs, or is it possible that AEC1 de-differentiation gives rise to these aberrant intermediate states? How does aging shift the trajectories of AECs in response to lung injury?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This manuscript examines genomic programs of alveolar type 2 cells (AEC2s) in uninjured and bleomycin-injured young and old mice. Three subsets of AEC2s were identified based on their single-cell gene signatures, which were correlated with processes such as progenitor cell renewal, inflammation, stress and aging. A human correlation was made from human lungs. The conclusion was that new insights into how aging and lung injury interact and synergize to potentially promote fibrosis.</p><p>The use of unbiased approaches (unclustered, single-cell RNA technology) is appropriate and innovative, as well as informative. The parallel studies of mouse and human lungs provides impactful, substantive credibility to the data. The data support the original hypothesis. Therefore, this is considered an important and impactful study.</p><p>The background literature is well covered, concise and the methodologies rigorous. The identification of 3 distinct sub-types of AEC2s, which shift w/age and in bleo-injury is of interest and may yield future targetable genes for a range of age- or injury-related processes. The lack of proof-of-concept or mechanisms in terms of demonstrating that the 3 sub-types have differential roles in promoting (or stopping) lung fibrosis confers a descriptive status to this manuscript. However, if the goal of this manuscript is to present initial single-cell findings to the public using mouse and human samples, then what is presented is sufficient.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.85415.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors employ single cell RNA sequencing of isolated alveolar type 2 cells (AEC2) to identify three clustered subsets that are influenced by age and lung injury. A synergistic effect of aging and lung injury contributed to impaired AEC2 recovery in aged mice after injury. Additionally, AEC2s from human idiopathic pulmonary fibrosis (IPF) revealed a similar transcriptomic signature to AEC2 subsets from bleomycin injured lungs from old mice. The studies are well done and provide new insights into how aging modulates the lung injury response in AECs.</p><p>With regard to the intermediate &quot;transitional&quot; states, the authors might consider performing RNA trajectory analysis to better define the dynamic changes and relationship between transcriptional states. For example, do the presumed transitional cells that express CLDN4 and keratin isoforms derive from healthy (young) AECs, or is it possible that AEC1 de-differentiation gives rise to these aberrant intermediate states? How does aging shift the trajectories of AECs in response to lung injury?</p></disp-quote><p>We thank the reviewer for the suggestion. We performed RNA trajectory analysis using Slingshot. The lineage differentiation potentials suggests that AEC2-3 cells were from subset AEC2-1 via subset AEC2-2. Interestingly, subset AEC2-3 also showed heterogeneity within the cluster, and some cells within this subset were further differentiated into AEC1 cells. The significance of AEC2-3 heterogeneity is unknown. There was slightly difference in the trajectory of AEC2-3 between young and old, possibly due to the difference in heterogeneity of AEC2-3. However, there is no clear evidence showing dedifferentiation of AEC1 into subset AEC2-3. Of course, careful lineage tracing studies are needed to confirm these transitions.</p><p>These data are added as Figure 2E.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This manuscript examines genomic programs of alveolar type 2 cells (AEC2s) in uninjured and bleomycin-injured young and old mice. Three subsets of AEC2s were identified based on their single-cell gene signatures, which were correlated with processes such as progenitor cell renewal, inflammation, stress and aging. A human correlation was made from human lungs. The conclusion was that new insights into how aging and lung injury interact and synergize to potentially promote fibrosis.</p><p>The use of unbiased approaches (unclustered, single-cell RNA technology) is appropriate and innovative, as well as informative. The parallel studies of mouse and human lungs provides impactful, substantive credibility to the data. The data support the original hypothesis. Therefore, this is considered an important and impactful study.</p><p>The background literature is well covered, concise and the methodologies rigorous. The identification of 3 distinct sub-types of AEC2s, which shift w/age and in bleo-injury is of interest and may yield future targetable genes for a range of age- or injury-related processes. The lack of proof-of-concept or mechanisms in terms of demonstrating that the 3 sub-types have differential roles in promoting (or stopping) lung fibrosis confers a descriptive status to this manuscript. However, if the goal of this manuscript is to present initial single-cell findings to the public using mouse and human samples, then what is presented is sufficient.</p></disp-quote><p>We thank the reviewer for the comments. We agree that further studies are needed to comprehensively demonstrate the roles and mechanisms of AEC2 subsets in aging and lung fibrosis. The study provided important resources to the research community.</p></body></sub-article></article>